Results 231 to 240 of about 1,118,075 (318)

Hyaluronic Acid vs. PRP, PRF, and Collagen in Regenerative Endodontics: A Systematic Review. [PDF]

J Clin Med
Ahmad AMF, Hijazi Alsadi T, Rodríguez AM, Hijazi Muwaquet K, Muwaquet Rodriguez S.   +4 more
europepmc   +1 more source

Comparing the Effect of Semi‐Immersive Virtual Reality, Computerized Cognitive Training, and Traditional Rehabilitation on Cognitive Function in Multiple Sclerosis: A Randomized Clinical Trial

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Cognitive impairment is a common non‐motor symptom in Multiple Sclerosis (MS), negatively affecting autonomy and Quality of Life (QoL). Innovative rehabilitation strategies, such as semi‐immersive virtual reality (VR) and computerized cognitive training (CCT), may offer advantages over traditional cognitive rehabilitation (TCR ...
Maria Grazia Maggio, Desiree Latella, Lilla Bonanno, Paulo Cezar Rocha dos Santos, Marcos Maldonado‐Díaz, Meir Plotnik, Rosaria De Luca, Angelo Quartarone, Rocco Salvatore Calabrò   +8 more
wiley   +1 more source

Clinical benefit and predictors of response to momelotinib after ruxolitinib failure: A cooperative real-world study. [PDF]

Cancer
Palandri F, Marchetti M, Elli EM, Isidori A, Gianesello I, Sartor C, Pugliese N, Di Perna M, Morsia E, Gallo S, Itri F, Montefusco V, Crisà E, Biagi A, Beggiato E, Mulas O, Benevolo G, Abruzzese E, Santoro M, Iurlo A, Calistri E, Rossi M, Martino B, Tiribelli M, Fava C, Dizdari A, Crugnola M, Duminuco A, Votto A, Guerzoni S, Caocci G, Pane F, Lanza F, Branzanti F, Dedola A, Salvatore F, Heidel FH, Breccia M, Palumbo GA, Kuykendall AT, Lucchesi A, Galimberti S.   +41 more
europepmc   +1 more source

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan, Lei Zhou, Jingzi ZhangBao, Hongmei Tan, Zhouzhou Wang, Chao Quan   +5 more
wiley   +1 more source

Spinal Cord Stimulators' Displacement: Systematic Review and Single-Institution Case Series with Anchoring Technique. [PDF]

J Pain Res
Mariadas R, Pan E, Boesel TW, Di Ieva A.
europepmc   +1 more source

Influenza Vaccination Responses in Disabled Stroke Patients: A Single‐Center Prospective Observational Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aimed to investigate the immunological response to influenza vaccination, the incidence and severity of influenza infection, and the side effects of the vaccination in patients with ischemic stroke. Methods This prospective observational study was conducted between 2023 and 2024 at Ramathibodi Hospital.
Achiraya Pakngao, Sureerat Suwatcharangoon, Pintip Ngamjanyapron, Kobporn Boonnak, Thanitta Suangtamai, Porpon Rotjanapan   +5 more
wiley   +1 more source

Intracardiac Versus Transesophageal Echocardiography for Left Atrial Appendage Occlusion: A Meta-Analysis. [PDF]

JACC Adv
Yaser H, Yaser S, Mohammed HE, Hanen G, Haseeb ME, Nasser M, Moubarak ES, Abu Mahfouz MM, Yassin MN, Manasrah A, Elgendy IY, Abuzaid AS.   +11 more
europepmc   +1 more source

Eventual permanence.

Notre Dame Journal of Formal Logic, 1980
openaire   +2 more sources

Dimethyl Fumarate, But Not Rituximab, Reduces Serum GFAP Levels and PIRMA in Relapsing–Remitting MS

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) levels are believed to reflect mainly acute and chronic disease processes in multiple sclerosis (MS), respectively. In this study, we investigated whether dimethyl fumarate (DMF) and rituximab (RTX) differentially affect these biomarkers.
F. Shawket, J. Lycke, J. Salzer, F. Piehl, K. Fink, N. Lange, J. Mellergård, C. Malmeström, P. Sundström, I. Erngren, A. al‐Grety, E. Freyhult, K. Kultima, J. Burman, A. Svenningsson   +14 more
wiley   +1 more source